关节内注射透明质酸对膝骨关节炎滑液的长期影响。
Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
作者信息
Bagga Hanish, Burkhardt Daniel, Sambrook Philip, March Lyn
机构信息
University of Sydney Institute of Bone and Joint Research, Royal North Shore Hospital, St. Leonards, NSW, Australia.
出版信息
J Rheumatol. 2006 May;33(5):946-50.
OBJECTIVE
Intraarticular (IA) hylan injections constitute second-line therapy for osteoarthritis (OA) of the knee, but human studies suggesting a possible mechanism of action are lacking. We examined the effect of IA Hylan GF-20 injections on synovial fluid (SF) hyaluronan (HA) concentration, viscosity, and elasticity over a 6-month period in patients with mild to moderate OA of the knees.
METHODS
Patients with symptomatic knee OA (Osteoarthritis Research Society International grade 1-2) had SF aspirated from the study knee pre- and 3 and 6 months post-Hylan injection. Primary endpoints included SF HA concentration, viscosity, and elasticity. SF HA concentration was determined using uronic acid assay, and rheology measured using a micro-Fourier rheometer.
RESULTS
Sequential SF samples were available from 32 of 60 subjects injected at baseline (15 men, 17 women; mean age 65 yrs) at 3 months post-injection. The mean HA concentration had increased by 13% (p<0.0008), and the complex shear modulus had increased by 16% (p<0.03). Sufficient SF was also available from 19 of these subjects at 6 months post-injection when mean HA concentration was 2.24+/-0.62 mg/ml compared to their baseline mean of 2.02+/-0.52 mg/ml, an increase of 10% (p<0.053).
CONCLUSION
This open-label study showed a statistically significant change from baseline in both SF HA concentration and complex shear modulus at 3 months following IA Hylan GF-20 injection among subjects with mild to moderate knee OA. These results suggest that one possible mechanism of action of viscosupplementation is to promote endogenous HA production. Longer-term studies are required to identify whether these changes in SF measures are important for modification of disease progression in knee OA.
目的
关节内(IA)注射透明质烷是膝关节骨关节炎(OA)的二线治疗方法,但缺乏提示其可能作用机制的人体研究。我们研究了IA注射透明质烷GF-20对轻至中度膝关节OA患者滑液(SF)透明质酸(HA)浓度、粘度和弹性在6个月期间的影响。
方法
有症状的膝关节OA患者(国际骨关节炎研究学会1-2级)在注射透明质烷前以及注射后3个月和6个月从研究膝关节抽取滑液。主要终点包括SF HA浓度、粘度和弹性。使用糖醛酸测定法测定SF HA浓度,并使用微型傅里叶流变仪测量流变学。
结果
在基线时注射的60名受试者中,有32名(15名男性,17名女性;平均年龄65岁)在注射后3个月有连续的SF样本。平均HA浓度增加了13%(p<0.0008),复合剪切模量增加了16%(p<0.03)。在这些受试者中,有19名在注射后6个月也有足够的SF,此时平均HA浓度为2.24±0.62mg/ml,而基线平均值为2.02±0.52mg/ml,增加了10%(p<0.053)。
结论
这项开放标签研究表明,在轻至中度膝关节OA患者中,IA注射透明质烷GF-20后3个月,SF HA浓度和复合剪切模量与基线相比有统计学上的显著变化。这些结果表明,粘弹性补充疗法的一种可能作用机制是促进内源性HA的产生。需要进行长期研究以确定SF指标的这些变化对于改变膝关节OA疾病进展是否重要。